Arab Pharmaceutical Industry Consulting/Pharmaceutical Research Unit
About Arab Pharmaceutical Industry Consulting/Pharmaceutical Research Unit
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pharmaceutical Research Unit, Jordan
7
Joint Stock Company "Farmak"
2
Nexgen Pharma, Inc
2
Clinical Trials at Arab Pharmaceutical Industry Consulting/Pharmaceutical Research Unit
During the past decade, Arab Pharmaceutical Industry Consulting/Pharmaceutical Research Unit conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Bioequivalence Study of Amlodipine / Losartan/ Hydrochlorothiazide of PHARMALINE, Lebanon Under Fastion Conditions
2012-10-01
2012-12-01
Completed
39
Bioequivalence Study of FLURBIPROFEN 100 mg FAMOTIDINE 20 mg MULTI-LAYER TABLET in Healthy Subjects Under Fasting Conditions
2012-12-01
2013-01-01
Completed
36
Single Dose Trial of Extended Release Combination Tablet Codeine and Guaifenesin
2014-06-01
2014-09-01
Completed
26
Bioequivalence Pilot Study of Dirithromycin of (Abdi İbrahim İlaç San.Ve.Tic.A.Ş,Turkey) in Healthy Subjects Under Fasting Condition
2014-06-01
2014-06-01
Completed
12
Bioequivalence Pilot Study of Dirithromycin of (Abdi İbrahim İlaç San.Ve.Tic.A.Ş,Turkey) in Healthy Subjects Under Fed Condition
2014-06-01
2014-06-01
Completed
12
Semi-replicate Crossover Bioequivalence Study of Dirithromycin of (Abdi İbrahim İlaç San. Ve Tic. A. Ş., Turkey) in Healthy Subjects Under Fasting Conditions
2014-12-01
2014-12-01
Completed
48
Semi-replicate Crossover Bioequivalence Study of Dirithromycin in Healthy Subjects Under Fed Conditions
2014-09-01
2014-10-01
Completed
48
COMPOUND (INN): HOE490O - GLIMEPIRIDE / METFORMIN HCl (Amaryl® M)0 (Glimepiride/Metformin Hydrochloride Immediate Release Combination Tablet) in Fed Conditions in Healthy Male and/or Female Subjects.
2015-05-01
2015-12-01
Withdrawn
0
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Arab Pharmaceutical Industry Consulting/Pharmaceutical Research Unit"
#1 collaborator was "Abdi Ibrahim Ilac San. ve Tic A.S." with 4 trials as a collaborator, "Pharmaceutical Research Unit, Jordan" with 1 trials as a collaborator and "Sanofi-aventis Liban SAL" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Arab Pharmaceutical Industry Consulting/Pharmaceutical Research Unit
According to Clinical.Site data, the most researched conditions in "Arab Pharmaceutical Industry Consulting/Pharmaceutical Research Unit" are
"Healthy" (6 trials), "Cough" (2 trials), "Pharmacokinetics" (2 trials) and "Fasting" (1 trials). Many other conditions were trialed in "Arab Pharmaceutical Industry Consulting/Pharmaceutical Research Unit" in a lesser frequency.
Clinical Trials Intervention Types at Arab Pharmaceutical Industry Consulting/Pharmaceutical Research Unit
Most popular intervention types in "Arab Pharmaceutical Industry Consulting/Pharmaceutical Research Unit" are "Drug" (11 trials). Other intervention types were less common.
The name of intervention was led by "DIRITHROMYCIN 500 MG ENTERIC COATED TABLET" (4 trials), "DYNABAC 250 MG ENTERIC COATED TABLET" (4 trials), "Progesterone 200 mg Soft Capsule (JSC "Farmak", Ukraine)" (2 trials), ": Amaryl® M IR 2/1000" (1 trials) and "ANTADYS® 100 mg, PEPCID® 20 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Arab Pharmaceutical Industry Consulting/Pharmaceutical Research Unit
The vast majority of trials in "Arab Pharmaceutical Industry Consulting/Pharmaceutical Research Unit" are
6 trials for "Male" genders, 3 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Arab Pharmaceutical Industry Consulting/Pharmaceutical Research Unit
Currently, there are NaN active trials in "Arab Pharmaceutical Industry Consulting/Pharmaceutical Research Unit".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Arab Pharmaceutical Industry Consulting/Pharmaceutical Research Unit,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Arab Pharmaceutical Industry Consulting/Pharmaceutical Research Unit, 11 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".